Magnetic resonance spectroscopy study in basal ganglia of patients with myoclonic epilepsy with ragged-red fibers

Neurology India

Volumn 55, Issue 4, 2007, Pages 385-387

  Chuang, Chieh Sen ^a   Lo, Man Chi ^a   Lee, Kwo Whei ^a   Liu, Chin San ^a  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Magnetic resonance spectroscopy; Myoclonic epilepsy with ragged red fibers

Indexed keywords

CREATINE; N ACETYLASPARTIC ACID;

ADOLESCENT; ADULT; ARTICLE; BASAL GANGLION; BRAIN MITOCHONDRION; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; FAMILY STUDY; FEMALE; HUMAN; MALE; MERRF SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

EID: 36549021548     PISSN: 00283886     EISSN: None     Source Type: Journal    
DOI: 10.4103/0028-3886.37096     Document Type: Article

References (11)

1. Barkovich AJ, Good WV, Koch TK, Berg BO. Mitochondrial disorders: Analysis of their clinical and imaging characteristics. AJNR Am J Neuroradiol 1993;14:1119-37.
2. Kendall BE. Disorder of lysosomes, peroxysomes and mitochondria. AJNR Am J Neuroradiol 1992;13:621-53.
3. Vedolin L, Moura de Souza CF, Schwark R, Lopes B, Laybauer LS, Saraiva Pereira ML, et al. Conventional MRI and MR spectroscopy in nonclassical mitochondrial disease: Report of three patients with mitochondrial DNA deletion. Childs Nerv Syst 2006;22:1355-9.
4. Mathews PM, Andermann F, Silver K, Karpati G, Arnold DL. Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies. Neurology 1993;43:2484-90.
5. Fukuhara N. MERRF: A clinicopathological study: Relationships between myoclonic epilepsies and mitochondrial myopathies. Rev Neurol 1991;147:476-9.
6. Parry A, Matthews PM. Roles for imaging in understanding the pathophysiology, clinical evaluation and management of patients with mitochondrial disease. J Neuroimaging 2003;13:293-302.
7. Kaufmann P, Shungu DC, Sano MC, Jhung S, Engelstad K, Mitsis E, et al. Cerebral lactic acidosis correlates with neurological impairment in MELAS. Neurology 2004;62:1297-302.
8. Orcesi S, Gorni K, Termine C, Uggetti C, Veggiotti P, Carrara F, et al. Bilateral putaminal necrosis associated with the mitochondrial DNA A8344G myoclonus epilepsy with ragged red fibers (MERRF) mutation: An infantile case. J Child Neurol 2006;21:79-82.
9. Kato T, Hamakawa H, Shioiri T, Murashita J, Takahashi Y, Takahashi S, et al. Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder. J Psychiatry Neurosci 1996;21:248-54.
10. Uyama E, Kutsukake Y, Hara A, Uemura K, Uchino M, Mita S, et al. Abnormal excretion of urinary phospholipids and sulfatide in patients with mitochondrial encephalomyopathies. Biochem Biophys Res Commun 1993;194:266-73.
11. Castillo M, Kwock L, Mukherji SK. Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol 1996;17:1-15.